Lipoid
Private Company
Funding information not available
Overview
Lipoid is a privately held, revenue-generating specialty ingredients company and a global pioneer in phospholipid manufacturing. With over 45 years of experience, it supplies essential lipid components for parenteral, oral, topical, and pulmonary drug delivery systems, playing a foundational role in commercializing complex formulations like mRNA vaccines and cancer therapeutics. The company operates four GMP-certified production plants in Germany, employs approximately 500 people, and serves pharmaceutical, nutraceutical, and cosmetic industries worldwide through a robust quality management system and extensive regulatory support.
Technology Platform
Specialized platform for the extraction, purification, modification, and formulation of natural, hydrogenated, and synthetic phospholipids. Enables the creation of advanced drug delivery systems like liposomes, lipid nanoparticles (LNPs), mixed micelles, and emulsions for pharmaceutical, nutraceutical, and cosmetic applications.
Opportunities
Risk Factors
Competitive Landscape
Lipoid is described as the world's only supplier of the full spectrum of natural, hydrogenated, and synthetic phospholipids, giving it a unique and dominant position. Competition exists from other specialty chemical and excipient suppliers (e.g., CordenPharma, NOF America, Avanti Polar Lipids) for specific phospholipid types, but Lipoid's scale, GMP focus, and comprehensive product range for pharmaceutical applications represent a significant competitive moat.